Apomorphine (hydrochloride)

Apomorphine ((-) -Apomorphine) hydrochloride is an orally active agonist of Dopamine receptor. Apomorphine hydrochloride can be used in study Parkinson, biphasic dyskinesias, urinary dysfunction, dystonia, dyspnoea, anismus and belching[1][2].

Product Specifications

CAS Number

[314-19-2]

Product Name Alternative

(-) -Apomorphine (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H312, H317, H332, H334

Target

5-HT Receptor; Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/apomorphine-hydrochloride.html

Purity

99.0

Smiles

OC1=CC=C2C(C3=C4C(CCN(C)[C@]4([H])C2)=CC=C3)=C1O.Cl

Molecular Formula

C17H18ClNO2

Molecular Weight

303.78

Precautions

H302, H312, H317, H332, H334

References & Citations

[1]Frankel JP, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53 (2) :96-101.|[2]Carbone F, et al. Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs. 2019 Sep;33 (9) :905-918.